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Abstract
A ubiquitination factor, NosA, is essential for cellular differentiation in Dictyostelium discoideum. In the absence of nosA,
development is blocked, resulting in a developmental arrest at the tight-aggregate stage, when cells differentiate into two
precursor cell types, prespore and prestalk cells. Development is restored when a second gene, encoding the ubiquitin-like
protein SonA, is inactivated in nosA-mutant cells. SonA has homology over its entire length to Dsk2 from Saccharomyces
cerevisiae, a ubiquitin-like protein that is involved in the assembly of the spindle pole body. Dsk2 and SonA are both stable
proteins that do not seem to be subjected to degradation via the ubiquitin pathway. SonA does not become ubiquitinated and
the intracellular levels of SonA are not affected by the absence of NosA. The high degree of suppression suggests that SonA
rescues most or all of the defects caused by the absence of nosA. We propose that NosA and SonA act in concert to control
the activity of a developmental regulator that must be deactivated for cells to cross a developmental boundary. ß 2000
Elsevier Science B.V. All rights reserved.
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1. Introduction
Eukaryotic cells synthesize proteins that retain cer-
tain signatures of ubiquitin and are known as ubiq-
uitin-like proteins [1]. While ubiquitin is conserved
among di¡erent species, ubiquitin-like proteins have
diverged widely, with homologies to ubiquitin that
range from 20% to 60%. All ubiquitin-like proteins
are expressed as fusions with C-terminal extensions.
One class contains ubiquitin-like proteins that lack
the amino acid determinants to be processed and
therefore, these proteins remain as fusion proteins,
containing the ubiquitin-like domain as an integral
part of a larger protein [1]. Ubiquitin-like domains of
such fusions do not become conjugated to target
proteins. Members of this class of ubiquitin-like pro-
teins include Parkin, Dsk2, and Rad23. These pro-
teins have been implicated in a variety of biological
processes, such as a familial form of juvenile Parkin-
son’s disease, chromosome segregation, and DNA
repair [2^6]. Yet another ubiquitin-like protein,
UBF1, acts as a virulence factor of Leishmania major
(S.M. Beverley, unpublished data).
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But what is the function of these ubiquitin-like
domains? Ubiquitin-like domains could act as pri-
mary degradation signals that become ubiquitinated
to target itself and the rest of the protein to the
proteasome for degradation. This mechanism has
been inferred from the discovery of the ubiquitin-
fusion degradation (UFD) pathway, in which model
fusions of ubiquitin and L-galactosidase are degraded
in such a manner [7]. That such a mechanism may
apply to ubiquitin-like proteins is supported by the
fact that ubiquitin can substitute for the ubiquitin-
like domain of Rad23 [5]. The ubiquitin-like domain
of Rad23 binds the proteasomal subunits cim1 and
cim5 and it is this interaction that regulates ubiqui-
tin-mediated degradation of Rad23 [6]. In vitro stud-
ies on human Rad23 suggest that the ubiquitin-like
domain becomes ubiquitinated by the E3 ubiquitin
ligase E6AP in conjunction with the E2 conjugating
enzymes UbcH7 and UbcH8 [8]. Whether ubiquiti-
nation of Rad23 is required for its degradation is not
known.
Another model that has been proposed for ubiq-
uitin-like domains is that they could also act as intra-
molecular chaperones for the C-terminal extensions,
as does ubiquitin. Expression of just the C-terminal
extension of the ubiquitin-fusion protein UBI3 does
not complement a null-mutation of the wild-type
gene, unless provided in multiple copies [9]. A similar
role could be assigned to the ubiquitin-like proteins,
which are also fused to a tail. The fact that the ubiq-
uitin-like domain cannot be removed might re£ect
the need for multiple folding/unfolding, which re-
quires the permanent presence of a chaperone.
Here, we report the identi¢cation of a novel ubiq-
uitin-like protein, which we named SonA, from the
cellular slime mold Dictyostelium discoideum. A mu-
tant allele of sonA restores development of a Dictyo-
stelium mutant that is a¡ected in the potential ubiq-
uitination factor NosA. The NosA gene was
previously identi¢ed in our laboratory by employing
a genetic screen to identify genes that are essential
for development of D. discoideum. Disruption of
nosA results in a developmental arrest at the tight-
aggregate stage, when cells di¡erentiate into two pre-
cursor cell types, prespore and prestalk cells. Several
proteins are stabilized in the nosA mutant, suggesting
that the role of NosA during development is to re-
move a speci¢c set of proteins to ensure developmen-
tal progression [10]. The developmental defect is
overcome when a mutant allele of sonA is introduced
into nosA mutant cells. The isolation of sonA estab-
lishes a genetic interaction between ubiquitin-like
proteins and NosA-dependent proteolysis.
The NosA homolog in Saccharomyces cerevisiae,
UFD2, was identi¢ed by its ability to recognize ubiq-
uitin-fusion proteins as substrates [7]. The similarity
of SonA and these arti¢cial substrates led us to ask
whether NosA targets the ubiquitin-like domain of
SonA. SonA does not become ubiquitinated and the
intracellular levels of SonA are not a¡ected by the
absence of NosA. We propose that NosA and SonA
act in concert to control the activity of a regulator
that must be deactivated for cells to develop.
2. Materials and methods
2.1. Strains
All mutants were created in a variant of Ax3 called
DH1, which is a uracil auxotroph [11]. The original
nosA-mutant strain R7 was derived from DH1 by
disruption of the nosA locus using pJB1 as described
in [10]. The plasmid pR7-Bcl, containing pJB1 and
nosA-£anking regions, was recovered from the mu-
tant R7, and reintroduced into DH1 to yield the
retransformant F11. Strain F11 was used for the
suppressor analysis.
2.2. Suppressor analysis
In order to isolate second-site mutations that re-
store normal development in the absence of nosA, the
nosA mutant F11 was transformed by REMI with
the BamHI-cut plasmid pBSR3. The plasmid
pBSR3 contains the gene conferring stable blasticidin
resistance upon integration of the plasmid into an
BamHI or DpnII site in the genome [12]. For this,
10 transformation reactions were prepared as fol-
lows: 8.5 ml of 107 cells/ml electroporation bu¡er
[10 mM sodium/potassium phosphate, 50 mM su-
crose, pH 6.1] were mixed with 260 Wg pBsR-3 and
260 U DpnII. Aliquots (0.8 ml) were transferred to
cooled 0.4-cm electroporation cuvettes and electro-
poration was carried out as described [13]. After
3 weeks of selection in HL5 medium [14] supple-
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mented with 5 Wg/ml blasticidin, resistant transform-
ants were allowed to form plaques on lawns of Kleb-
siella aerogenes. After 4 days, plates were inspected
for fruiting bodies. Spores from these fruiting bodies
were collected and treated with 0.2% Triton X-100
for 30 min. Detergent-resistant spores were plated on
SM plates with K. aerogenes [14]. Fruiting bodies
derived from this plating underwent a second round
of detergent treatment. Axenic cultures were derived
from clonal populations for each suppressor, which
were stored at 380‡C. To determine which clones
were independent, Southern blots with the radio-
labeled BglIII/XhoI-fragment of pUCBsrvBam on
NdeI- and BclI-restricted genomic DNA of each
strain was carried out [12]. From this, ten independ-
ent suppressors were isolated. SonA suppressor strain
3-3 was analyzed in this study.
2.3. Northern and Southern blots
DNA and RNA blotting techniques were done as
previously described [15], except that Nytran mem-
branes (Schleicher and Schuell) were used to blot
RNA. A probe speci¢c to sonA was prepared by
ampli¢cation of a fragment (0.22 kb) from the
sonA-cDNA using the primers son1-E (5P-GATGTT-
GATGTCGAGTTAG-3P) and son1-D (5P-GGTAC-
TTGTTGTTCAACTGG-3P). This polymerase chain
reaction (PCR) product was puri¢ed on a low-melt-
ing-temperature agarose gel and labeled by random
priming [16].
2.4. Immunoprecipitation and Western blots
Protein blotting techniques were performed as de-
scribed previously [10]. Immunoprecipitation of
FLAG-tagged SonA was carried out as described
[17]. FLAG(M2) (3.3 Wg) from Sigma was used for
each immunoprecipitation.
2.5. Pulse-chase analysis
Cells from mid-log cultures were collected by cen-
trifugation (1500Ug ; 4 min). Cells were washed once
with fresh HL5 and resuspended in pulse-medium
(HL5 supplemented with 20 Wg/ml uracil, 0.2% fetal
bovine serum (HyClone), and 0.75 mCi/ml Trans35S-
Label with a speci¢c activity of 1.2 mCi/mmol
(ICN)) at a concentration of 107 cells/ml. Cells
were shaken at 150 rpm at 22‡C for 2 h and pelleted.
Cells were washed twice with chase medium (HL5
containing 20 Wg/ml uracil, 0.2% fetal bovine serum,
20 mM methionine, and 20 mM cysteine) and resus-
pended in chase medium at a concentration of
1U107 cells/ml. Cells were returned to the shaker
and samples of 1U107 cells were taken at the indi-
cated times. Cells were pelleted by centrifugation
(14 000Ug, 5 s), washed with SorC (16.7 mM
Na2H/KH2PO4, 50 WM CaCl2, pH 6.0) and lysed
in 1 ml TENT (50 mM Tris^HCl (pH 8.0), 2 mM
EDTA, 150 mM NaCl, 1% Triton X-100) containing
protease inhibitors. Samples were snap-frozen in dry-
ice and stored at 320‡C until use for immunopreci-
pitations as described above. Incorporation of radio-
labeled [35S]methionine and [35S]cysteine was deter-
mined by protein precipitation with trichloroacetic
acid (TCA) as described [18]. About 1.2^1.7U107
cpm were detected in the insoluble protein fraction
derived from 107 cells.
3. Results
3.1. Isolation of the sonA-1 allele as a suppressor of
nosA
We previously isolated the NosA gene in a genetic
screen to identify genes that are essential for cellular
di¡erentiation in D. discoideum [13]. NosA is a po-
tential ubiquitination factor that is homologous to
UFD2 from S. cerevisiae [19]. The disruption of
nosA causes a developmental arrest of D. discoideum
at the tight aggregation stage [10]. We suggested that
NosA is required for the degradation of negative
regulators of the spore cell lineage that need to be
removed in order for cells to continue development.
Candidates for such regulators are three proteins
that accumulate as ubiquitin conjugates in nosA-mu-
tant cells [10]. We designed a genetic suppressor
screen to identify genes encoding substrates and in-
teracting partners of NosA. By de¢nition, such sup-
pressors would allow nosA-de¢cient cells to complete
development and to form spores. This approach pro-
vides the means for a selection: spores can be se-
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lected by detergent treatment which kills non-encap-
sulated cells, but leaves spores intact. NosA-mutant
cells were mutagenized to introduce second-site
mutations that rescue the developmental defect, lead-
ing to the formation of fruiting bodies with viable
spores. About 8U108 nosA-mutant cells were trans-
formed in 100 independent REMI (restriction-endo-
nuclease-mediated-integration) mutagenesis reactions
with the restriction enzyme DpnII and the BamHI-
restricted plasmid, pBSR3. This screen yielded about
84 000 transformants. A total of 24 000 transform-
ants was examined individually as plaques growing
on bacterial lawns of K. aerogenes. Thirty-one colo-
nies produced fruiting bodies with opaque sorocarps,
indicating the presence of spores. Southern blot anal-
ysis with various enzymes showed that the 31 sup-
pressors produced 10 di¡erent restriction enzyme
mapping patterns. The assumption that those ten
transformants were a¡ected in di¡erent genes was
con¢rmed when the regions £anking the insertion
sites were sequenced. These transformants were
named Son for suppressors of nosA. The suppressors
can be divided into two classes. One class contains
mutant alleles of genes that encode proteins related
to the ubiquitin system or proteolysis, including the
ubiquitin-like protein SonA, and a putative AAA-
type protease (SonD). The other class of suppressors
contain novel genes that may function as bypass sup-
pressors, or encode novel components of the ubiqui-
tination system.
3.2. The mutant allele of sonA restores development of
a nosA mutant
Suppression of the nosA mutation was e⁄cient, as
shown in Fig. 1. NosA-mutant cells aggregate and
form mounds but do not proceed with development
(Fig. 1, middle panel). A second-site mutation in the
sonA gene releases the arrest and allows cells to form
fruiting bodies (Fig. 1, left panel) that are indistin-
guishable from those formed by wild-type cells (Fig.
1, right panel). Such e⁄cient suppression is true for
all 10 independent suppressors that emerged from
this screen. The creation of the same sonA-1 mutant
allele in a wild-type background did not produce any
obvious phenotype (data not shown). This result in-
dicates that sonA is not essential for growth or devel-
opment, which is also true for the homologs dsk2
and dph1 in S. cerevisiae, and Schizosaccharomyces
pombe, respectively [2,20].
3.3. Creation of sonA-1/nosA double mutants by
homologous recombination
To test whether the sonA-1 mutant allele is respon-
sible for suppressing the developmental arrest of the
nosA mutant, we created mutants by homologous
recombination. We recovered a DNA fragment
from the original nosA/sonA-1 mutant, which con-
tains pBSR3 and the £anking regions of sonA-1.
This DNA fragment was introduced into the nosA
Fig. 1. Suppressors of nosA. The ¢nal developmental stages of the nosA/sonA-1 double mutant (left panel), nosA mutant (middle pan-
el), and wild-type (left panel). All photographs are taken from colonies that consumed a bacterial lawn and completed development.
Note the tight aggregates with a bacterial lawn in the background of the middle panel. While the nosA mutant sometimes makes soro-
carps with empty sori, the suppressors all produce detergent resistant spores. The average height of a fruiting body is V2 mm. The
other suppressors strains were equally restored (see text for details).
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mutant to recreate the nosA/sonA-1 suppressor
strain. As shown in Fig. 2A, the genomic DNA
from these transformants was restricted with BclI
and was studied by Southern blot analysis using a
speci¢c probe for the plasmid pBSR3. A 7.5 kb frag-
ment was identi¢ed in transformants (Fig. 2A, lanes
2^5) with suppressed phenotype that matched the
size of the fragment derived from the original nosA/
sonA-1 suppressors (lane 1). Transformants with a
non-suppressed phenotype had the plasmid inserted
at random sites in the genome (Fig. 2A, lanes 7^11).
The insertion of pBSR3 into the sonA locus was con-
¢rmed by PCR analysis (Fig. 2B). Transformants
with a suppressed phenotype carried the sonA-1 mu-
tant allele (Fig. 2B, lanes 2^5), while transformants
with a non-suppressed phenotype had an intact sonA
locus (Fig. 2B, lanes 7^11). This correlation between
the site of integration and suppression indicates that
it is the mutation of sonA that suppresses the e¡ect
of the nosA mutation.
3.4. The sonA-1 mutant allele produces a truncated
transcript
The insertion of the selectable plasmid pBSR3 into
codon 158 of sonA allows nosA-mutant cells to over-
come the developmental arrest and to complete de-
velopment. To determine the nature of this insertion-
al mutation, we studied the expression of nosA in
normal and suppressed nosA-mutant cells. As shown
in Fig. 2C, the insertion of pBSR3 causes the expres-
sion of a truncated transcript of 1.0 kb, compared to
the transcript size of 2.1 kb found in the parental
strain. This transcript may be translated as a trun-
cated version of SonA. If this is the case, truncated
SonA would consist mainly of the ubiquitin-like do-
main, because pBSR3 inserted downstream from the
sonA region that encodes the ubiquitin-like domain.
Expression is low during growth and early aggrega-
tion, and peaks during later aggregation and mound
formation (8^12 h of development). Later in develop-
Fig. 2. Insertional mutation of sonA by homologous recombination rescues development and gives rise to a truncated sonA transcript.
(A) nosA-mutant cells were transformed with the rescued plasmid containing the £anking regions of sonA. Development of nine trans-
formants was observed and divided into two classes: transformants with suppressed wild-type phenotype (lanes 2^5) and transform-
ants with a nosA phenotype (lanes 7^11). Genomic DNA was isolated from these transformants and analyzed on Southern blots using
a probe speci¢c to the blasticidin resistance marker, and PCR to determine which transformants had the plasmid inserted into the
sonA gene. One Wg of genomic DNA was digested with BclI (lane 1, the original suppressor 3-3; lanes 2^11, transformants). The
DNA was size-fractionated on 1% agarose gels and transferred to nylon membranes. The integration site of the plasmid was deter-
mined by hybridization with a probe generated from the gene conferring blasticidin resistance. (B) Genomic DNA was subjected to
PCR with a set of three primers that would amplify a PCR product of 640 bp from intact sonA and a PCR product of 875 bp from
mutated sonA*. (C) Five Wg of total RNA from growing amoebae of wild-type (DH1), nosA-mutant (F11), and nosA/sonA-1 double-
mutant (F10-1) was size-fractionated on a 1% agarose gel, transferred to nitrocellulose, and hybridized to a probe corresponding to
sonA. The sonA transcripts are indicated by arrows. Equal loading was con¢rmed by ethidium bromide staining of the ribosomal
bands (not shown).
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Fig. 3. Nucleotide and predicted amino acid sequence of SonA. The cDNA of SonA was derived as a single fragment from screening
a spore germination-speci¢c D. discoideum V-Zap library. This fragment includes the open reading frame of SonA from nucleotide +1
to +1569 and a 5P UTR (untranslated region) of 145 bp and a 3P UTR of 31 bp. The nucleotide numbers are indicated at the left of
the sequence. Splice junctions are indicated by shading the two nucleotides (#181^182) that are fused due to the splicing event. The
insertion site of pBSR3 is boxed. The sonA gene encodes a 523-amino-acid protein. The protein sequence is indicated under each co-
don with the amino acid numbers indicated on the right side of the sequence. The ubiquitin-like domain is underlined. The UBA do-
main (ubiquitin-binding domain) is highlighted.
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ment, the transcript level decreases to a plateau that
corresponds to the level observed during growth. The
insertional mutation does not interfere with the ex-
pression pattern of sonA (data not shown).
3.5. The suppressor SonA codes for a ubiquitin-like
protein
The full-length cDNA for sonA was obtained by
screening a lambda-ZAP cDNA library. Analysis of
this cDNA clone indicates that SonA has an open
reading frame of 1569 nucleotides, which codes for
a protein with a calculated mass of 56.7 kDa. SonA
contains a 77-residue-long ubiquitin-like domain
fused to a C-terminal extension of 446 amino acids
(Fig. 3). SonA lacks the amino acid determinants to
be cleaved downstream of the ubiquitin-like domain,
and therefore belongs to a family of stable ubiquitin-
like proteins. Such fusions are not cleaved, and do
not become conjugated to other proteins [1]. SonA
has homology over its entire length to Dsk2 from S.
cerevisiae (Fig. 4). Dsk2 is involved in spindle pole
body (SPB) formation (centrosomes in vertebrates)
[2]. Dsk2 is a stable nuclear protein that, when mu-
tated, can complement the de¢ciency to duplicate
spindle bodies caused by the absence of the structural
SPB component kar1. The mutant allele contains a
point mutation that results in a His69Tyr substitu-
tion. Overexpression of wild-type Dsk2 or its C-ter-
minal extension without the ubiquitin-like domain
does not complement the kar1 mutation. These
data demonstrate the vital role of the ubiquitin-like
domain for the function of Dsk2. The Dsk2 homolog
of S. pombe, Dph1, has a function similar to Dsk2,
and its overexpression causes a cell cycle arrest at
metaphase [20].
BLAST homology searches [21] with the SonA se-
quence established homology to other proteins with
ubiquitin-like domains that are similar to ubiquitin.
SonA carries a conserved sequence motif at the C-
terminus, known as the UBA domain (ubiquitin-as-
sociated domain). We identi¢ed the UBA domain of
SonA by searching the Prosite database (version 15)
[22,23]. The UBA domain is included in the Prosite
database under the accession number PS50030. The
UBA domain has an estimated length of 55 amino
Fig. 4. A comparison of Dsk2 and SonA. Alignment of SonA and Dsk2 using the GCG-Best¢t algorithm. Identical residues are indi-
cated by black boxes, conserved residues are indicated by shaded boxes. The ubiquitin-like domains lack the glycine doublet in posi-
tions 76 and 77 which are required for cleaving the ubiquitin-like domains. Therefore, SonA and Dsk2 stay as fusion proteins and are
not conjugated to other proteins. There is a long insert in SonA that contains multiple GGM repeats. The function of the GGM re-
peats, if any, is unknown.
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acids, based on proteins with multiple copies
arranged as tandem arrays. The conserved region
of the UBA domain is about 45 residues long and
is believed to form an K-helix [24]. The UBA domain
has been shown to bind ubiquitin non-covalently. In
the case of the cellular protein p62, deletion of the
UBA domain abolishes the capacity to bind ubiqui-
tin [25]. The UBA domain can be found in all known
stable ubiquitin-like proteins, a variety of E2-conju-
gating enzymes, E3-ligating enzymes, and ubiquitin
carboxy terminal hydrolases (for review see [24]).
3.6. Intracellular levels of SonA do not depend on the
activity of the proteasome or NosA
The isolation of sonA-1 establishes a genetic inter-
action between a ubiquitin-like protein and NosA.
The arti¢cial substrates used by Varshavsky and co-
workers to identify the NosA homolog UFD2 were
fusion proteins with ubiquitin fused to L-galactosi-
dase [7]. SonA shares features with these ubiquitin-
L-galactosidase fusions: SonA is expressed as a fu-
sion protein with a domain at its N-terminus that is
61% similar to ubiquitin. The homology between the
ubiquitin^L-galactosidase fusions and SonA raised
the question whether the NosA/UFD2 pathway
acts on ubiquitin-like domains rather than on ubiq-
uitin. UFD2 is a ubiquitination factor that is re-
quired for extending ubiquitin chains on target pro-
teins [19]. The sequence homology between UFD2
and NosA suggests that NosA has a similar role in
Dictyostelium. If the role of NosA is to assemble
multi-ubiquitin chains onto SonA to target SonA
to the proteasome for degradation, we should detect
an increase in SonA concentrations when the protea-
some is blocked. A similar e¡ect would be expected
in the absence of NosA, because SonA would be
insu⁄ciently ubiquitinated and therefore not recog-
nized by the proteasome. We subjected growing wild-
type and nosA-mutant cells that express SonA-
FLAG to the cell-permeable proteasome inhibitor
MG132 [26] and monitored the levels of SonA over
a period of 6 h (Fig. 5A). We observed that both
wild-type and nosA-mutant cells respond to the
MG132 treatment: ubiquitin conjugates accumulate
when the drug is administered (Fig. 5A). The accu-
mulation of ubiquitin-conjugates is an indication that
the proteosome is inhibited. In contrast, the concen-
trations of SonA are not a¡ected by the presence of
the proteasome inhibitor MG132 or the absence of
NosA. The levels of SonA were also not a¡ected in
similar experiments, in which we monitored the turn-
over of SonA in pulse-chased nosA-mutant and wild-
type cells, in the presence or absence of MG132 (data
not shown). These ¢ndings show that the intracellu-
lar levels of SonA are not controlled by ubiquitin-
mediated proteolysis involving the activity of NosA.
Fig. 5. Intracellular concentrations of SonA do not depend on
NosA or the proteasome. (A) Wild-type (DH1) and nosA-mu-
tant cells (F11) expressing SonA-FLAG were shaken in suspen-
sion (4U106 cells/ml) in the absence or presence of 100 WM
MG132 (Calbiochem). 107 cells were harvested at the indicated
times and lysed. Upper panel : SonA-FLAG was immunopreci-
pitated with KFLAG-M2 and the precipitate was size-fraction-
ated on 12.5% sodium dodecyl sulfate (SDS)^polyacrylamide
gels. The Western blot was reacted with KFLAG-M2 (Sigma;
1:2000 dilution). Lower panel: lysates equal to 5U105 cells
were prepared for Western blot analysis as described above.
The blot was reacted with an antibody against ubiquitin (Sig-
ma; 1:100 dilution). (B) Pulse-chase of [35S]SonA-FLAG. Wild-
type (DH1) and nosA-mutant cells (F11) expressing SonA-
FLAG were pulsed with 0.75 mCi/ml 35S-Translabel (ICN) for
120 min in suspension (HL5) at a concentration 2U107 cells/
ml. Cells were washed with cold medium (HL5) and chased for
up to 240 min at a concentration of 1U107 cells/ml. Aliquots
of 107 cells were removed at the indicated times. Labeled
SonA-FLAG was precipitated with KFLAG-M2, size-fractionat-
ed on a 12.5% SDS^polyacrylamide gel, and detected by phos-
phor imaging.
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To determine the half-life of SonA and to test
whether SonA becomes ubiquitinated, wild-type cells
and nosA-mutant cells were labeled with
[35S]methionine for 120 min and chased for 240
min (Fig. 5B). SonA is present at about the same
levels in wild-type and nosA-mutant cells, and there
is no appearance of ubiquitinated intermediates in
either cell line. A subtle decrease in SonA concentra-
tions could be observed between the 120-min and
240-min time point. We can, therefore estimate a
half-life for SonA as 4 h or greater. This slow de-
crease in SonA levels is not due to continued incor-
poration of [35S]methionine during the chase period,
which would counteract the degradation of SonA by
newly synthesized labeled SonA. We monitored the
incorporation of [35S]methionine during the pulse
and chase periods and found that no signi¢cant
amount of [35S]methionine was incorporated during
the chase (6 5%). We conclude that SonA is a stable
protein that is not subjected to rapid degradation by
the ubiquitin system.
4. Discussion
The results presented here establish a genetic inter-
action between the ubiquitin system, a ubiquitin-like
protein, and development. We previously identi¢ed
the NosA gene, which encodes a potential ubiquiti-
nation factor [10,19]. NosA is homologous to UFD2
from S. cerevisiae, which binds ubiquitinated model
substrates and catalyzes the elongation of multi-
ubiquitin chains [19]. The NosA homolog UFD2
from S. cerevisiae was isolated as a result of its abil-
ity to degrade model substrates that contain a ubiq-
uitin domain [7]. Disruption of nosA results in a
developmental arrest at the tight-aggregation stage,
when cells start to di¡erentiate into two precursor
cell types, prespore and prestalk cells. The develop-
mental phenotype of nosA-mutant cells may be due
to the failure to remove these proteins, which could
act as negative regulators of cellular di¡erentiation.
Ubiquitin-like domains have also been shown to
function as sites of ubiquitination that target the
protein to the proteasome for degradation [6]. The
homology between these arti¢cial substrates and
SonA raised the question whether a similar mecha-
nism applies to SonA, in which the ubiquitin-like
domain of SonA becomes ubiquitinated by NosA.
If this were true, NosA-dependent degradation of
SonA would be required for cells to proceed with
development. We did not ¢nd any evidence that
this is the case: the intracellular levels of SonA in
vivo are not in£uenced by blocking ubiquitin-medi-
ated proteolysis or by removing NosA from cells.
The mechanism of suppression must therefore be dif-
ferent from simply controlling the intracellular levels
of SonA.
As shown in Fig. 1, suppression of the nosA mu-
tation is very e⁄cient. NosA-mutant cells that carry a
sonA-1 mutant allele complete development, which is
indistinguishable from wild-type development. This
e⁄cient suppression suggests to us that SonA rescues
most or all of the defects caused by the absence of
nosA. We speculate that SonA is an antagonist of
NosA, and acts on the same substrate. A model
that is consistent with the presented results is shown
in Fig. 6. The observed suppression of the nosA mu-
tation may be accomplished by deactivating a devel-
opmental regulator that accumulates in nosA cells
and which prevents developmental progression. Can-
didates for such regulators are three proteins that
accumulate as ubiquitin-conjugates in nosA-mutant
cells [10]. SonA contains a ubiquitin-like domain
and a UBA-domain, both of which have the capacity
to bind other proteins [6,27]. If SonA binds the
Fig. 6. Model for the biochemical interaction between NosA
and SonA (see text for details).
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putative developmental regulator through one of
these domains as shown in Fig. 6, this developmental
regulator may become activated upon binding. We
propose that the activated regulator acts as an inhib-
itor of cellular di¡erentiation (Fig. 6). The activated
developmental regulator would need to be removed
from cells, so that the organism can proceed past the
tight aggregation stage of development. In this mod-
el, the removal of the developmental regulator does
not take place in nosA-mutant cells, because NosA is
not present to target the complex for degradation.
The lack of ubiquitination results in the accumula-
tion of activated regulator, which causes a develop-
mental arrest. The introduction of the sonA-1 mutant
allele into these nosA cells rescues development. The
mutant form of SonA may not have the capacity to
activate the developmental regulator, which leaves
the developmental regulator in the deactivated
form. Due to the absence of nosA in these cells, the
developmental regulator would accumulate in its de-
activated from, which would not interfere with the
cell’s capacity to complete development.
Elucidating the molecular basis of the interaction
between SonA and NosA may help to understand
the biology of ubiquitin-like proteins, including those
like parkin that are involved in disease. The isolation
of a mutant allele of sonA as a genetic suppressor of
NosA links SonA to regulated proteolysis and to
development. The elegant genetics and biochemistry
of Dictyostelium puts us in a position to understand
the role of the ubiquitin-like protein SonA during
cellular di¡erentiation.
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